Ixico (LON:IXI) posted its quarterly earnings results on Tuesday. The company reported GBX (2) (($0.03)) earnings per share (EPS) for the quarter, missing the consensus estimate of GBX (1.50) (($0.02)) by GBX (0.50) (($0.01)), Bloomberg Earnings reports.
IXI opened at GBX 20 ($0.26) on Thursday. Ixico has a 1 year low of GBX 22.20 ($0.29) and a 1 year high of GBX 39.99 ($0.52).
ILLEGAL ACTIVITY NOTICE: This article was first published by Dakota Financial News and is owned by of Dakota Financial News. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The correct version of this article can be read at https://dakotafinancialnews.com/2018/12/06/ixico-ixi-announces-quarterly-earnings-results-misses-estimates-by-0-50-eps.html.
IXICO plc provides technology enabled services to the biopharmaceutical industry worldwide. The company's technologies include Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, QC, and reading/analysis to reporting and data transfer.
Read More: Preferred Stock
Receive News & Ratings for Ixico Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ixico and related companies with MarketBeat.com's FREE daily email newsletter.